I agree IPIX has a lot to sell. Do not forget Dr Bertilino is a dermatologist and Brilacidin has many possible as well as profitable dermatologic indications including huge markets for acne, eczema and atopic dermaitis. Other possible indications include Hidradenitis suppurativa Diabetic ulcers, eye and ear infections.

IPIX has already begun preparations for topical dermatologic Brilacidin.

http://www.ipharminc.com/new-blog/2017/6/5/br...ermatology

Brilacidin's effect on Interleukin-17 in skin and mucosal membranes may open other potential uses.

https://www.researchgate.net/publication/3016...n_diseases